期刊文献+

帕金森病人运动并发症发生机制研究

Study of Motor Complications in Parkinsonian Patients
下载PDF
导出
摘要 目的探讨帕金森病人运动并发症的发生机制及帕金森病人的最佳治疗方案。方法66例帕金森病人,主要观察年龄、性别、病程、多巴胺剂量、多巴胺疗程与运动并发症的关系。结果帕金森病人年龄、病程、多巴胺剂量、多巴胺疗程与运动波动及异动症有关。结论帕金森病人病程、多巴胺剂量、多巴胺疗程是运动并发症的独立危险因素,年龄是保护性因素。 Objective: To explore the mechanism of motor complications and to explore the best way treatment in parkinsonian patients. Methods: 66 cases with parkinsonian patients. The mainly analysed were age,at onset of PD, sex, disease duration, dosage of levodopa( LD), duration of LD treatment and relation to motor complications. Results: Disease duration,dosage of LD, duration of LD treatment related to the development of motor factors fluctuations and dyskinesias. Conclusion: Disease duration,dosage of LD,duration of LD treatment were independent factors for the development of motor complications.
出处 《泰山医学院学报》 CAS 2006年第8期697-699,共3页 Journal of Taishan Medical College
关键词 帕金森病 左旋多巴 运动并发症 parkinson' s disease levodopa motor complication
  • 相关文献

参考文献6

  • 1Brannan T,Yahr MD.Comparative study of selegiline plus L-dopa-carbidopa verus L-dopa-carbidopa alone in the treatment of Parkinson's disease[J].Ann Neurol,1995,37(1):95-98.
  • 2王新德.帕金森病及帕金森综合征的诊断标准[J].中华神经精神科杂志,1985,18:256-256.
  • 3Hastings TG.Enzymatic oxidation of dopamine:the role of prostaglandin H synthase[J].J Neurochem,1995,64(2):919-924.
  • 4Jones DC,GDunasekar PG,Browitz JL,et al.Dopamine-induced apoptosis is mediated by oxidative stress and is enhanced by cyanide in differentiation PC12 cells[J].J Neurochem,2000,74(6):2296-2304.
  • 5Tandberg E,Larsen JP,Nessler EG,et al.Age at onset and clinical outcome in idiopathic Parkinson's disease[J].Neurology,1985,35(suppl 1):276.
  • 6Markham CH,Diamond SG,Hoehn MM.Multicenter study of Parkinson moltality with early verus later dopa treatment[J].Ann Neurol,1987,22(1):8-12.

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部